Skip to Content

'
Valerie I. Reed, M.D.

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2003 Duke University School of Medicine, Durham, NC, MD, Medicine

Postgraduate Training

2004-2008 Clinical Residency, Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
2003-2004 Clinical Internship, Internal Medicine, Greater Baltimore Medical Center, Baltimore, MD

Honors and Awards

2004 Intern of the Year, Greater Baltimore Medical Center
2003 Janet M. Glasgow Achievement Citation (awarded to female medical students who graduate in the top 10% of their class)
2002 Alpha Omega Alpha Medical Honor Society
2002 National Medical Association Fellowship in Academic Medicine
1999 Dean's Tuition Scholarship, Duke University School of Medicine
1999 Honors in the Liberal Arts, The Ohio State University
1999 Summa Cum Laude, The Ohio State University
1998 Phi Kappa Phi (top 5% of class)

Selected Publications

Peer-Reviewed Original Research Articles
1. Reed VK, Krishnan S, Mansfield PF, Bhosale PR, Kim M, Das P, Janjan NA, Delclos ME, Lowy AM, Feig BW, Pisters PW, Ajani JA, Crane CH. Incidence, natural history, and patterns of locoregional recurrence in gastric cancer patients treated with preoperative chemoradiotherapy. Int J Radiat Oncol Biol Phys 71(3):741-7, 7/2008. PMID: 18164837.
2. Reed VK, Cavalcanti JL, Strom EA, Perkins GH, Oh JL, Tereffe W, Yu TK, Yeung H, Whitman GJ, Bedrosian I, Macapinlac HA, Buchholz TA, Woodward WA. Risk of Subclinical Micrometastatic Disease in the Supraclavicular Nodal Bed According to the Anatomic Distribution in Patients with Advanced Breast Cancer. Int J Radiat Oncol Biol Phys 71(2):435-40, 6/2008. PMID: 18164831.
3. Talbot J, Ibom VK, Rizzieri DA. Barrier R, Niedzwieki d, DeCastro CM, Moore JO, Buckley P, Laney R, Stevenson D, Rumbaugh H, Gockerman JP. Dose-Intense Cyclophosphamide and Etoposide for Patients With Refractory or High-Risk Non-Hodgkin's Lymphoma. Clin Lymphoma 5(2):116-122, 9/2004.
4. Ibom VK, Prosnitz RG, Gong JZ, Moore JO, DeCastro CM, Prosnitz LR, Rizzieri DA, Gockerman JP. Rituximab in Lymphocyte Predominance Hodgkin's Disease: A Case Series. Clin Lymphoma 4(2):115-118, 9/2003.
5. Rizzieri DA, Ibom VK, Moore JO, DeCastro CM, Rosner GL, Adams DJ, Foster T, Payne N, Thompson M, Vredenburgh JJ, Gasparetto C, Long GD, Chao NJ, Gockerman JP. Phase I Evaluation of Prolonged-Infusion Gemcitabine With Fludarabine for Relapsed or Refractory Acute Myelogenous Leukemia. Clin Cancer Res 9(2):663-668, 2/2003.

Last updated: 12/18/2012